• Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact
Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer
  • Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact

Archives

Monthly Archive for: "December, 2020"
 Nascent Biotech Receives Full IND Clearance to Begin Phase I Human Trials for Brain Cancer
0
By Nascent Biotech
In Corporate News, News, Press Releases, Science News
Posted December 15, 2020

Nascent Biotech Receives Full IND Clearance to Begin Phase I Human Trials for Brain Cancer

SAN DIEGO, CA / ACCESSWIRE / December 15, 2020 / Nascent Biotech, Inc. (OTCQB:NBIO) On December 7, the Company received a letter from the US Food and Drug Administration (FDA) removing a partial [...]

READ MORE
© NASCENT BIOTECH, INC. ALL RIGHTS RESERVED.